[Development trends for therapeutic antibody].

Eishi Baba, Hitoshi Kusaba, Shuji Nakano

Research output: Contribution to journalReview article

Abstract

Recent developments for therapeutic antibody have provided new options for cancer treatments. Modification of antibody molecules pursuing improvement of binding efficacy for Fcgamma receptors and enabling efficient recycling of antibody have been performed. Novel constructs of antibody possessing multivalent specificity and conjugated agents have also been developed. Based on exploration of new class of target molecules for therapeutic antibody, antibodies enhancing anti-tumor immunity such as anti-CTLA-4 antibody have appeared. These advancements would achieve more effective and safer therapy for various kinds of cancers.

Original languageEnglish
Pages (from-to)2098-2103
Number of pages6
JournalNihon rinsho. Japanese journal of clinical medicine
Volume70
Issue number12
Publication statusPublished - Jan 1 2012

Fingerprint

Antibodies
Therapeutics
Neoplasms
Blocking Antibodies
Recycling
Anti-Idiotypic Antibodies
Immunity

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

[Development trends for therapeutic antibody]. / Baba, Eishi; Kusaba, Hitoshi; Nakano, Shuji.

In: Nihon rinsho. Japanese journal of clinical medicine, Vol. 70, No. 12, 01.01.2012, p. 2098-2103.

Research output: Contribution to journalReview article

@article{8cdf7aa254f646c0a02e2f62035b4b3c,
title = "[Development trends for therapeutic antibody].",
abstract = "Recent developments for therapeutic antibody have provided new options for cancer treatments. Modification of antibody molecules pursuing improvement of binding efficacy for Fcgamma receptors and enabling efficient recycling of antibody have been performed. Novel constructs of antibody possessing multivalent specificity and conjugated agents have also been developed. Based on exploration of new class of target molecules for therapeutic antibody, antibodies enhancing anti-tumor immunity such as anti-CTLA-4 antibody have appeared. These advancements would achieve more effective and safer therapy for various kinds of cancers.",
author = "Eishi Baba and Hitoshi Kusaba and Shuji Nakano",
year = "2012",
month = "1",
day = "1",
language = "English",
volume = "70",
pages = "2098--2103",
journal = "Astrophysical Journal",
issn = "0004-637X",
publisher = "IOP Publishing Ltd.",
number = "12",

}

TY - JOUR

T1 - [Development trends for therapeutic antibody].

AU - Baba, Eishi

AU - Kusaba, Hitoshi

AU - Nakano, Shuji

PY - 2012/1/1

Y1 - 2012/1/1

N2 - Recent developments for therapeutic antibody have provided new options for cancer treatments. Modification of antibody molecules pursuing improvement of binding efficacy for Fcgamma receptors and enabling efficient recycling of antibody have been performed. Novel constructs of antibody possessing multivalent specificity and conjugated agents have also been developed. Based on exploration of new class of target molecules for therapeutic antibody, antibodies enhancing anti-tumor immunity such as anti-CTLA-4 antibody have appeared. These advancements would achieve more effective and safer therapy for various kinds of cancers.

AB - Recent developments for therapeutic antibody have provided new options for cancer treatments. Modification of antibody molecules pursuing improvement of binding efficacy for Fcgamma receptors and enabling efficient recycling of antibody have been performed. Novel constructs of antibody possessing multivalent specificity and conjugated agents have also been developed. Based on exploration of new class of target molecules for therapeutic antibody, antibodies enhancing anti-tumor immunity such as anti-CTLA-4 antibody have appeared. These advancements would achieve more effective and safer therapy for various kinds of cancers.

UR - http://www.scopus.com/inward/record.url?scp=84875808557&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875808557&partnerID=8YFLogxK

M3 - Review article

C2 - 23259380

AN - SCOPUS:84875808557

VL - 70

SP - 2098

EP - 2103

JO - Astrophysical Journal

JF - Astrophysical Journal

SN - 0004-637X

IS - 12

ER -